INFLAMMATION-RELATED GENE
    92.
    发明公开
    INFLAMMATION-RELATED GENE 审中-公开
    点火相关基因

    公开(公告)号:EP1261640A2

    公开(公告)日:2002-12-04

    申请号:EP01925373.1

    申请日:2001-03-05

    申请人: Novartis AG

    CPC分类号: C07K14/705

    摘要: The use of (A) a polypeptide comprising the amino acid sequence of SEQ ID NO:2, or a functionally equivalent variant of that amino acid sequence, or (B) a polynucleotide comprising a nucleotide sequence encoding the polypeptide (A), or (C) an antibody which is immunoreactive with the polypeptide (A), or (D) an antisense oligonucleotide comprising a nucleotide sequence complementary to that of polynucleotide (B), or (E) a polynucleotide probe comprising at least 15 consecutive nucleotides of (B), in the preparation of a pharmaceutical for the diagnosis or treatment of a neutrophil-associated inflammatory disease.

    COMBINATION OF N-PHENYL-N'-BENZOYL UREA DERIVATIVE AND NECTIN COMPOUNDS FOR PARASITE CONTROL
    96.
    发明公开
    COMBINATION OF N-PHENYL-N'-BENZOYL UREA DERIVATIVE AND NECTIN COMPOUNDS FOR PARASITE CONTROL 有权
    合并及伊维菌素啶蜱脲组成抗寄生虫

    公开(公告)号:EP1244359A1

    公开(公告)日:2002-10-02

    申请号:EP00985086.8

    申请日:2000-11-23

    IPC分类号: A01N43/90

    摘要: An active ingredient combination for the simultaneous control of ecto- and endoparasites, especially mites, ticks and nematodes, on productive livestock, domestic animals and pets, is described, which comprises the active ingredients (1) 1-[4-chloro-3-(3-chloro-5-trifluoromethyl-2-pyridyloxy)phenyl]-3-(2,6-difluorobenzoyl)urea and (2) a compound of formula (i) wherein R1 is hydrogen or one of radicals (ii) or (iii), R2 is CH(CH3)-CH3, -CH(CH3)-C2H5, -C(CH3)=CH-CH(CH3)2 or cyclohexyl; R3 is hydrogen or hydroxy if the bond between atoms 22 and 23 represents a double bond, or is hydrogen or the group =N-O-CH3 if a single bond is present between atoms 22 and 23; and R4 is HO- or HO-N=, in free form or in the form of a physiologically acceptable salt.

    CONTACT LENS
    98.
    发明公开
    CONTACT LENS 有权
    隐形眼镜

    公开(公告)号:EP1236068A1

    公开(公告)日:2002-09-04

    申请号:EP00982514.2

    申请日:2000-12-07

    IPC分类号: G02C7/04 B29D11/00 C08F30/08

    摘要: This invention is directed to ophthalmic materials and ophthalmic lenses that are a co-polymerization product of a (a) hydrophilic monomer with (b) a tris(siloxy)silyl group-containing monomer, (c) a wide variety of hydrophobic monomers (both aliphatic and aromatic) and usually a (d) polyfluorinated monomer, as well as optional monomers or monomer mixtures that can include a cationic monomer, a non-aromatic hydrophobic monomer and a poly(dimethylsiloxy)silyl group-containing monomer. A contact lens prepared from such a co-polymer exhibits enhanced water content, while maintaining exceptional oxygen permeability, thereby providing a lens that can be worn comfortably for prolonged periods of time. A process for the preparation of such lenses is also disclosed.

    摘要翻译: 本发明涉及作为(a)亲水单体与(b)含三(甲硅烷氧基)甲硅烷基的单体的共聚产物的眼科材料和眼镜片,(c)多种疏水单体 (d)多氟化单体,以及任选单体或单体混合物,其可以包括阳离子单体,非芳族疏水单体和含聚(二甲基甲硅烷氧基)甲硅烷基的单体。 由这种共聚物制备的隐形眼镜表现出增强的含水量,同时保持优异的透氧性,从而提供可以长时间舒适地佩戴的镜片。 还公开了制备这种镜片的方法。

    VALNEMULIN FORMULATION
    99.
    发明公开
    VALNEMULIN FORMULATION 有权
    INIERZIERBARE沃尼妙林配方

    公开(公告)号:EP1235566A2

    公开(公告)日:2002-09-04

    申请号:EP00990671.0

    申请日:2000-12-07

    IPC分类号: A61K31/22 A61K47/12 A61K47/10

    摘要: The preparation of an improved galenic delivery form of valnemulin, which is notable for its good tolerance and stability in storage, is described. The new delivery form in question is a non-aqueous or oily injection formulation, which is obtainable by means of in situ preparation and subsequent stabilisation of the free, relatively unstable base of the active ingredient. A further aspect of the present invention concerns the usage of such an injection formulation in a method of treating infectious diseases in productive livestock or domestic animals.